Genetic Toxicology Testing Global Market Report 2025
상품코드:1825745
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
유전자 독성 검사 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 CAGR 9.2%로 25억 6,000만 달러로 성장할 것입니다. 예측 기간의 성장은 새로운 식품에 대한 시험 수요 증가, 잠재적 위험에 대한 우려 증가, 환경 및 건강에 대한 관심 증가, 규제 당국의 감시 강화, in vitro 시험법 사용 증가, 하이스루풋 스크리닝 플랫폼의 부상 등에 기인할 것으로 예상됩니다. 예측 기간의 주요 동향으로는 정밀의료와 독성유전체학의 발전, 종합적인 리스크 커뮤니케이션, 유전자 독성 검사 방법, 리스크 평가 방법의 발전, 오믹스 기술의 통합, 유전체학 및 분자생물학의 발전 등이 있습니다.
향후 5년간 9.2%의 성장률 전망은 지난번 전망치보다 0.8% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 장벽은 독일과 일본에서 조달하는 암스 테스트 키트와 염색체 이상 측정 시약의 비용을 상승시켜 미국을 저해하고, 의약품의 안전성 평가를 지연시키며, 의약품 개발 비용을 상승시킬 것으로 예상됩니다. 또한, 상호 관세와 무역 마찰 및 제한 강화로 인한 세계 경제 및 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.
맞춤형 의료에 대한 수요의 급증은 향후 몇 년간 유전자 독성 검사 시장의 확대를 견인할 것으로 예상됩니다. 개인맞춤의료는 예측된 반응과 질병 위험에 따라 환자 개개인에게 맞춤화된 개입과 제품을 제공하는 의료 접근법으로, 유전학적 발전, 질병에 대한 이해의 향상, 바이오마커 기반 진단의 가용성, 가치 기반 의료에 대한 노력, 임상 진료 및 연구와의 통합을 통해 지지를 받고 있습니다. 지지를 모으고 있습니다. 유전독성 검사는 유전자의 다양성, 유전독성 물질에 대한 감수성, 치료 반응에 대한 중요한 인사이트를 제공함으로써 맞춤의료에서 중요한 역할을 하고 있습니다. 예를 들어, 2024년 2월 개인맞춤의료연합(Personalized Medicine Coalition)이 보고한 바와 같이, FDA는 2023년 희귀질환 환자를 위한 16개의 맞춤형 신약을 승인했으며, 이는 2022년 6개에서 크게 증가한 수치입니다. 이처럼 맞춤형 의료에 대한 수요 증가는 유전자 독성 검사 시장의 촉매제 역할을 하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 유전자 독성 검사 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 유전자 독성 검사 시장 : 성장률 분석
세계의 유전자 독성 검사 시장 실적 : 규모와 성장, 2019-2024
세계의 유전자 독성 검사 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 유전자 독성 검사 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 유전자 독성 검사 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
In vitro(체외)
In vivo
세계의 유전자 독성 검사 시장 : 제품별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
서비스
시약 및 소모품
어세이
세계의 유전자 독성 검사 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
헬스케어 업계
식품 업계
화장품 업계
농업 산업
기타 용도
세계의 유전자 독성 검사 시장 : 하위 세분화 체외 시험, 종류별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
에임즈 테스트
미소핵시험
혜성 어세이
염색체 이상 검사
세포 형질전환 어세이
기타 체외 시험법
세계의 유전자 독성 검사 시장 : 하위 세분화 생체내, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
미소핵시험(설치류)
혜성 어세이(생체내)
골수 염색체 이상 검사
우성 치사 시험(설치류)
기타 생체 안쪽법
제7장 지역별·국가별 분석
세계의 유전자 독성 검사 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 유전자 독성 검사 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
유전자 독성 검사 시장 : 경쟁 구도
유전자 독성 검사 시장 : 기업 개요
F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Quest Diagnostics Incorporated
Eurofins Scientific SE
SGS SA
WuXi AppTec
Intertek Group plc
Charles River Laboratories International Inc.
PerkinElmer Inc.
Bio-Rad Laboratories Inc.
Fraunhofer ITEM
Jubilant Life Sciences Limited
Evotec SE
Inotiv Inc.
Promega Corporation
Syngene International Limited
Nelson Laboratories LLC
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
유전자 독성 검사 시장 2029 : 새로운 기회를 제공하는 국가
유전자 독성 검사 시장 2029 : 새로운 기회를 제공하는 부문
유전자 독성 검사 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
KSM
영문 목차
영문목차
Genetic toxicology testing is a specialized field within toxicology dedicated to assessing the potential of chemical substances to cause damage to genetic material, including DNA, RNA, and chromosomes. Its primary objective is to determine the genotoxicity of compounds and identify any adverse effects they may have on the genetic material of living organisms, including humans. This testing serves as a crucial tool for evaluating the safety of pharmaceuticals, chemicals, and environmental pollutants, particularly concerning genotoxic hazards.
The primary classifications within the genetic toxicology testing market include in vitro and in vivo methodologies. In vitro testing refers to experiments or studies conducted in a controlled laboratory environment, such as test tubes, petri dishes, or other artificial settings, without the involvement of living organisms. Various products encompass services, reagents, consumables, and assays, utilized across diverse applications spanning the healthcare, food, cosmetics, agriculture industries, among others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The genetic toxicology testing market research report is one of a series of new reports from The Business Research Company that provides genetic toxicology testing market statistics, including the genetic toxicology testing industry's global market size, regional shares, competitors with a genetic toxicology testing market share, detailed genetic toxicology testing market segments, market trends, and opportunities, and any further data you may need to thrive in the genetic toxicology testing industry. This genetic toxicology testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The genetic toxicology testing market size has grown rapidly in recent years. It will grow from $1.63 billion in 2024 to $1.8 billion in 2025 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to rising public health crises, increasing globalization, increased focus on personalized medicine, rising demand for rigorous testing solutions, and an increasing number of drugs.
The genetic toxicology testing market size is expected to see strong growth in the next few years. It will grow to $2.56 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to rising demand for testing novel foods, rising concerns about potential risks, rising environmental and health concerns, increasing regulatory scrutiny, increasing use of in vitro testing methods, and the rise of high-throughput screening platforms. Major trends in the forecast period include advances in precision medicine and toxicogenomic, comprehensive risk communication, genetic toxicology testing methodologies, advancing risk assessment methodologies, integration of omics technologies, and advancements in genomics and molecular biology.
The forecast of 9.2% growth over the next five years reflects a modest reduction of 0.8% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of Ames test kits and chromosomal aberration assay reagents sourced from Germany and Japan, thereby delaying drug safety evaluations and elevating pharmaceutical development costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The surge in demand for personalized medicine is anticipated to drive the expansion of the genetic toxicology testing market in the coming years. Personalized medicine, a healthcare approach that tailors interventions and products to individual patients based on their predicted response or disease risk, has gained traction due to genetic advancements, improved disease understanding, biomarker-based diagnostics availability, value-based healthcare initiatives, and integration into clinical practice and research. Genetic toxicology testing plays a vital role in personalized medicine by furnishing crucial insights into genetic variability, susceptibility to genotoxic agents, and treatment response. For instance, as reported by the Personalized Medicine Coalition in February 2024, the FDA greenlit 16 new personalized medicines for rare disease patients in 2023, a significant increase from six in 2022. Thus, the growing demand for personalized medicine serves as a catalyst for the genetic toxicology testing market.
Major players in the genetic toxicology testing market are concentrating on developing innovative drug screening platforms such as phenotypic drug screening to enhance accuracy and efficiency in identifying potential genetic toxins. Phenotypic drug screening involves testing compounds based on their capacity to elicit a specific cellular or physiological response in a whole organism or relevant cell system. For example, in August 2022, Creative Biogene, a US-based biotechnology company, unveiled zebrafish disease models tailored to support drug discovery and toxicology research. These models replicate human genetic diseases in zebrafish, offering insights into disease mechanisms, drug discovery, and toxicology. Creative Biogene's zebrafish models serve as a valuable tool for evaluating drug toxicity, predicting the safety of novel compounds, and bolstering the drug development pipeline.
In September 2024, Scantox Group, a Denmark-based contract research organization, acquired Gentronix for an undisclosed amount. This acquisition enables Scantox to enhance its portfolio by incorporating Gentronix's expertise in genetic toxicology testing. Gentronix Ltd., a UK-based company, specializes in providing accurate genetic toxicology testing services.
Major companies operating in the genetic toxicology testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, SGS SA, WuXi AppTec, Intertek Group plc, Charles River Laboratories International Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Fraunhofer ITEM, Jubilant Life Sciences Limited, Evotec SE, Inotiv Inc., Promega Corporation, Syngene International Limited, Nelson Laboratories LLC, Instem, Frontage Laboratories Inc., Creative Bioarray, Creative Biolabs Inc., Gentronix Limited, MB Research Laboratories.
North America was the largest region in the genetic toxicology testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genetic toxicology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the genetic toxicology testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The genetic toxicology testing market includes revenues earned by entities through mutagenicity testing, genotoxicity screening, carcinogenicity testing, regulatory compliance, risk assessment, bacterial mutation assays, comet assays, micronucleus tests, presymptomatic testing, ancestry testing, and nutrigenomics testing, and related cell culture systems, assay kits, microscopes, flow cytometers, automation and robotics, and flow cytometry. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Genetic Toxicology Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on genetic toxicology testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for genetic toxicology testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The genetic toxicology testing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: In Vitro; In Vivo
2) By Product: Services; Reagents And Consumables; Assays
3) By Application: Healthcare Industry; Food Industry; Cosmetics Industry; Agriculture Industry; Other Applications
Subsegments:
1) By In Vitro: Ames Test; Micronucleus Assay; Comet Assay; Chromosomal Aberration Test; Cell Transformation Assay; Other In Vitro Methods
2) By In Vivo: Micronucleus Test (Rodent); Comet Assay (In Vivo); Bone Marrow Chromosomal Aberration Test; Dominant Lethal Test (Rodent); Other In Vivo Methods
Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Merck KGaA; Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; Eurofins Scientific SE; SGS SA; WuXi AppTec; Intertek Group plc; Charles River Laboratories International Inc.; PerkinElmer Inc.; Bio-Rad Laboratories Inc.; Fraunhofer ITEM; Jubilant Life Sciences Limited; Evotec SE; Inotiv Inc.; Promega Corporation; Syngene International Limited; Nelson Laboratories LLC; Instem; Frontage Laboratories Inc.; Creative Bioarray; Creative Biolabs Inc.; Gentronix Limited; MB Research Laboratories
3. Genetic Toxicology Testing Market Trends And Strategies
4. Genetic Toxicology Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Genetic Toxicology Testing Growth Analysis And Strategic Analysis Framework
5.1. Global Genetic Toxicology Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Genetic Toxicology Testing Market Growth Rate Analysis
5.4. Global Genetic Toxicology Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Genetic Toxicology Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Genetic Toxicology Testing Total Addressable Market (TAM)
6. Genetic Toxicology Testing Market Segmentation
6.1. Global Genetic Toxicology Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
In Vitro
In Vivo
6.2. Global Genetic Toxicology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Services
Reagents And Consumables
Assays
6.3. Global Genetic Toxicology Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Healthcare Industry
Food Industry
Cosmetics Industry
Agriculture Industry
Other Applications
6.4. Global Genetic Toxicology Testing Market, Sub-Segmentation Of In Vitro, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ames Test
Micronucleus Assay
Comet Assay
Chromosomal Aberration Test
Cell Transformation Assay
Other In Vitro Methods
6.5. Global Genetic Toxicology Testing Market, Sub-Segmentation Of In Vivo, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Micronucleus Test (Rodent)
Comet Assay (In Vivo)
Bone Marrow Chromosomal Aberration Test
Dominant Lethal Test (Rodent)
Other In Vivo Methods
7. Genetic Toxicology Testing Market Regional And Country Analysis
7.1. Global Genetic Toxicology Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Genetic Toxicology Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion